https://www.selleckchem.com/pr....oducts/Cyclosporin-A
The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. This research aims to identify the priority areas and summarize core actions for advancing RS for traditional medicines in China. A mixed approach of documentary analysis of government policies, regulations and official information about TCM
Like
Comment
Share
